Hims & Hers (HIMS 5.66%) has had a rough go of it in 2026, but a recent deal with Novo Nordisk (NVO 2.14%) may bring the company's operations back to life. The Wegovy pill is one of the products coming to Hims & Hers, and we now know details of what that launch will look like, and it could make this a high-growth stock by the end of 2026. In this video, I explain why this launch is so exciting.
*Stock prices used were end-of-day prices of March 18, 2026. The video was published on March 20, 2026.





